References
- Addington D, Addington J, Patten S: Gender and affect in schizophrenia. Can J Psychiatry 41:265-268, 1996
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC, American Psychiatric Association, 1994
- Andreasen NC, Olsen S: Negative vs positive schizophrenia: definition and validation. Arch Gen Psychiatry 39:789-794, 1982
- Atre-Vaidya N, Taylor MA: Effectiveness of lithium in schizophrenia: do we really have an answer? J Clin Psychiatry 50:170-173, 1989
- Bandelow B, Muller P, Gaebel WE: Depressive syndromes in schizophrenic patients after discharge from hospital. Eur Arch Psychiatry Clin Neurosci 240:113-120, 1991
- Barnes TR, Curson DA, Liddle PF, et al: The nature and prevalence of depression in chronic schizophrenic in-patients. Br J Psychiatry 154:486-491, 1989
- Bartels SJ, Drake RE: Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 29:467-483, 1988
- Bartels SJ, Drake RE, McHugo GJ: Alcohol abuse, depression and suicidal behavior in schizophrenia. Am J Psychiatry 149:394-395, 1992
- Becker RE: Implications of the efficacy of thiothixene and a chlorpromazineimipramine combination for depression in schizophrenia. Am J Psychiatry 140:208-211, 1983
- Bermanzohn PC, Siris SG: Akinesia: A syndrome common to parkinsonism, retarded depression, and negative symptoms. Compr Psychiatry 33:221-232, 1992
- Berrios GE, Bulbena A: Post psychotic depression: the Fulbourn cohort. Acta Psychiatr Scand 76:89-93, 1987
- Birchwood M, Mason R, Macmillan F, et al: Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 23:387-395, 1993
- Bland RC, Newman SC, Orn H: Schizophrenia: lifetime co-morbidity in a community sample. Acta Psychiatr Scand 75:383-391, 1987
- Bleuler E: Dementia Praecox, or the Group of Schizophrenias (1911). New York, International Universities Press, 1950
- Bodkin AJ, Cohen BM, Salomon MS, et al: Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. J Nerv Ment Dis 184:295-301, 1996
- Bowers MD, Astrachan BM: Depression in acute schizophrenia. Am J Psychiatry 123:976-979, 1967
- Bucci L: The negative symptoms of schizophrenia and the monoamine oxidase inhibitors. Psychopharmacology (Berl) 91:104-108, 1987
- Caldwell CB, Gottesman II: Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull 16:571-589, 1990
- Carpenter WT Jr, Heinrichs DW, Alphs LD: Treatment of negative symptoms. Schizophr Bull 11:440-452, 1985
- Chien CP, DiMascio A, Cole JD: Antiparkinson agents and depot phenothiazines. Am J Psychiatry 131:86-90, 1984
- Christison GW, Kirch DG, Wyatt RJ: When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 17:217-240, 1991
- Coryell W, Keller M, Lavori P, et al: Affective syndromes, psychotic features, and prognosis, I: depression. Arch Gen Psychiatry 47:651-657, 1990
- Crow TJ: Molecular pathology of schizophrenia: more than one disease process? BMJ 280:66-68, 1980
- Davis KL, Kahn RS, Ko G, et al: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486, 1991
- DeAlarcon R, Carney MWP: Severe depressive mood changes following slowrelease intramuscular fluphenazine injection. BMJ 3:564-567, 1969
- de Figueiredo JM: Depression and demoralization: phenomenologic differences and research perspectives. Compr Psychiatry 34:308-311, 1993
- Docherty JP, van Kammen DP, Siris SG, et al: Stages of onset of acute schizophrenic psychosis. Am J Psychiatry 135:720-726, 1978
- Drake RE, Cotton PG: Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry 148:554-559, 1986
- Drake RE, Ehrlich J: Suicide attempts associated with akathisia. Am J Psychiatry 142:499-501, 1985
- Dufresne RL, Kass DJ, Becker RE: Buproprion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia. Drug Development Research 12:259-266, 1988
- Eissler KR: Remarks on the psycho-analysis of schizophrenia. Int J Psychoanal 32:139-156, 1951
- Falloon I, Watt DC, Shepherd M: A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med 8:59-70, 1978
- Fleischhaker WW, Roth SD, Kane JM: The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol 10:12-21, 1990
- Floru L, Heinrich K, Wittek F: The problem of post-psychotic schizophrenic depressions and their pharmacological induction. International Pharmacopsychiatry 10:230-239, 1975
- Frank JD: Persuasion and Healing. Baltimore, MD, Johns Hopkins University Press, 1973
- Galdi J: The causality of depression in schizophrenia. Br J Psychiatry 142:621-625, 1983
- Galdi J, Rieder RO, Silber D, et al: Genetic factors in the response to neuroleptics in schizophrenia: a pharmacogenetic study. Psychol Med 11:713-728, 1981
- Goff DC, Midha KK, Sarid-Segal O, et al: A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology (Berl) 117:417-423, 1995
- Goldstein JM, Link BG: Gender and the expression of schizophrenia. J Psychiatr Res 22:141-155, 1988
- Goldstein JM, Tsuang MT: Gender and schizophrenia: an introduction and synthesis of findings. Schizophr Bull 16:179-183, 1990
- Goldstein JM, Santangelo SL, Simpson JC, et al: The role of gender in identifying subtypes of schizophrenia: a latent class analytic approach. Schizophr Bull 16:263-275, 1990
- Green MF, Nuechterlein KH, Ventura J, et al: The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. Am J Psychiatry 147:179-182, 1990
- Haas GL, Glick ID, Clarkin JF, et al: Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention. Schizophr Bull 16:277-292, 1990
- Hafner H, Maurer K, Loffler W, et al: The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br J Psychiatry 164 (suppl 23):29-38, 1994
- Hallonquist JD, Seeman MV, Lang M, et al: Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 33:207-209, 1993
- Halstead SM, Barnes TRE, Speller JC: Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br J Psychiatry 164:177-183, 1994
- Harrow M, Yonan CA, Sands JR, et al: Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved? Schizophr Bull 20:327-338, 1994
- Heilä H, Isometsä ET, Henriksson MM, et al: A nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 154:1235-1242, 1997
- Herz M: Prodromal symptoms and prevention of relapse in schizophrenia. J Clin Psychiatry 46 (no 11, sec 2):22-25, 1985
- Herz M, Melville C: Relapse in schizophrenia. Am J Psychiatry 137:801-805, 1980
- Hirsch SR, Gaind R, Rohde PD, et al: Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. BMJ 1(854):633-637, 1973
- Hirsch SR, Jolley AG, Barnes TRE, et al: Dysphoric and depressive symptoms in chronic schizophrenia. Schizophr Res 2:259-264, 1989
- Hogarty GE, Munetz MR: Pharmacogenic depression among outpatient schizophrenic patients: a failure to substantiate. J Clin Psychopharmacol 4:17-24, 1984
- Hogarty GE, Anderson CM, Reiss DJ, et al: Family psychoeducational, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, 1: one-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 43:633-642, 1986
- Johnson DAW: Depressions in schizophrenia: some observations on prevalence, etiology, and treatment. Acta Psychiatr Scand 63 (suppl 291):137-144, 1981a
- Johnson DAW: Studies of depressive symptoms in schizophrenia. Br J Psychiatry 139:89-101, 1981b
- Johnson DAW: The significance of depression in the prediction of relapse in chronic schizophrenia. Br J Psychiatry 152:320-323, 1988
- Kessler RC, McGonagle KA, Swartz M, et al: Sex and depression in the National
- Comorbidity Survey, I: lifetime prevalence, chronicity, and recurrence. J Affect Disord 29:85-96, 1993
- Klein DF: Endogenomorphic depression: a conceptual and terminological revision. Arch Gen Psychiatry 31:447-454, 1974
- Knights A, Hirsch SR: "Revealed" depression and drug treatment for schizophrenia. Arch Gen Psychiatry 38:806-811, 1981
- Koreen AR, Siris SG, Chakos M, et al: Depression in first episode schizophrenia. Am J Psychiatry 150:1643-1648, 1993
- Kramer MS, Vogel WH, DiJohnson C, et al: Antidepressants in 'depressed' schizophrenic inpatients: a controlled trial. Arch Gen Psychiatry 46:922-928, 1989
- Kuck J, Zisook S, Moranville JT, et al: Negative symptomatology in schizophrenic outpatients. J Nerv Ment Dis 180:510-515, 1992
- Kurland AA, Nagaraju A: Viloxazine and the depressed schizophrenic: methodological issues. J Clin Pharmacol 21:37-41, 1981
- Lavin MR, Siris SG, Mason SE: What is the clinical importance of cigarette smoking in schizophrenia? Am J Addict 5:189-208, 1996
- Leff J, Tress K, Edwards B: The clinical course of depressive symptoms in schizophrenia. Schizophr Res 1:25-30, 1988
- Lerner Y, Mintzer Y, Schestatzky M: Lithium combined with haloperidol in schizophrenic patients. Br J Psychiatry 153:359-362, 1988
- Levitt JJ, Tsuang MT: The heterogeneity of schizoaffective disorder: implications for treatment. Am J Psychiatry 145:926-936, 1988
- Lewine R: Schizophrenia: An amotivational syndrome in men. Can J Psychiatry 30:316-318, 1985
- Lindenmayer J-P, Grochowski S, Kay SR: Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms. Compr Psychiatry 32:528-533, 1991
- Mandel MR, Severe JB, Schooler NR, et al: Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry 39:197-203, 1982
- Martin RL, Cloninger RC, Guze SB, et al: Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 46 (no 11, sec 2):9- 13, 1985
- McGlashan TH, Bardenstein KK: Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 16:319-329, 1990
- McGlashan TH, Carpenter WT Jr: An investigation of the postpsychotic depressive syndrome. Am J Psychiatry 133:14-19, 1976a
- McGlashan TH, Carpenter WJ Jr: Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 33:231-239, 1976b
- Miles C: Conditions predisposing to suicide. A review. J Nerv Ment Dis 164:221- 246, 1977
- Miller JB, Sonnenberg SM: Depression following psychotic episodes: a response to the challenge of change? J Am Acad Psychoanal 1:253-270, 1973
- Moller HJ, von Zerssen D: Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull 8:109-117, 1982
- Moller HJ, von Zerssen D: Handbook of Studies on Schizophrenia. New York, Elsevier, 1986
- Norman RMG, Malla AK: Dysphoric mood and symptomatology in schizophrenia. Psychol Med 21:897-903, 1991
- Norman RMG, Malla AK: Correlation over time between dysphoric mood and symptomatology in schizophrenia. Compr Psychiatry 35:34-38, 1994
- Nuechterlein KH, Dawson MD: A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 10:300-312, 1984
- Perenyi A, Goswami U, Frecska E, et al: L-Deprenyl in treating negative symptoms of schizophrenia. Psychiatry Res 42:189-191, 1992
- Plasky P: Antidepressant usage in schizophrenia. Schizophr Bull 17:75-98, 1991
- Prasad AJ, Kumar N: Suicidal behavior in hospitalized schizophrenics. Suicide Life Threat Behav 18:265-269, 1988
- Prusoff BA, Williams DH, Weissman MM, et al: Treatment of secondary depression in schizophrenia. Arch Gen Psychiatry 36:569-575, 1979
- Riecher-Rossler A, Hafner H, Stumbaum M, et al: Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20:203-214, 1994
- Rifkin A, Quitkin F, Klein DF: Akinesia: a poorly recognized drug-induced extrapyramidal behavioral disorder. Arch Gen Psychiatry 32:672-674, 1975
- Rifkin A, Quitkin F, Kane JM, et al: Are prophylactic antiparkinson drugs necessary? Arch Gen Psychiatry 35:483-489, 1978
- Roth S: The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. Am J Psychiatry 127:51-58, 1970
- Roy A: Suicide in chronic schizophrenia. Br J Psychiatry 141:171-177, 1982
- Roy A: Do neuroleptics cause depression? Biol Psychiatry 19:777-781, 1984
- Roy A: Depression, attempted suicide and suicide in patients with chronic schizophrenia. Psychiatr Clin North Am 9:193-206, 1986
- Roy A, Thompson R, Kennedy S: Depression in chronic schizophrenia. Br J Psychiatry 142:465-470, 1983
- Sands JR, Harrow M: Depression during the longitudinal course of schizophrenia. Schizophr Bull 25:157-171, 1999
- Seeman MV: The role of estrogen in schizophrenia. J Psychiatry Neuroscience 21:123-127, 1996a
- Seeman MV: Schizophrenia, gender, and affect. Can J Psychiatry 41:263-264, 1996b
- Seeman MV: Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154:1641-1647, 1997
- Semrad EV: Long-term therapy of schizophrenia: formulation of the clinical approach, in Psychoneuroses and Schizophrenia. Edited by Usdin GP. Philadelphia, PA, JB Lippincott, 1966, pp 155-173
- Shear K, Frances A, Weiden P: Suicide associated with akathisia and depot fluphenazine treatment. J Clin Psychopharmacol 3:235-236, 1983
- Shtasel DL, Gur RE, Gallacher F, et al: Gender differences in the clinical expression of schizophrenia. Schizophr Res 7:225-231, 1992
- Silver H, Nassar A: Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study. Biol Psychiatry 31:698-704, 1992
- Singh AN, Saxena B, Nelson HL: A controlled clinical study of trazodone in chronic schizophrenic patients with pronounced depressive symptomatology. Current Therapeutics Research 23:485-501, 1978
- Siris SG: Akathisia and "acting-out." J Clin Psychiatry 46:395-397, 1985
- Siris SG: Implications of normal brain development for the pathogenesis of schizophrenia (letter). Arch Gen Psychiatry 45:1055, 1988
- Siris SG: Diagnosis of secondary depression in schizophrenia: implications for DSM-IV. Schizophr Bull 17:75-98, 1991
- Siris SG: Depression and schizophrenia, in Schizophrenia. Edited by Hirsch SR, Weinberger DR. Cambridge, MA, Blackwell Science, 1995, pp 128-145
- Siris SG: The treatment of schizoaffective disorder, in Current Psychiatric Therapy II. Edited by Dunner DL. Philadelphia, PA, WB Saunders, 1996, pp 196-201
- Siris SG: Depression in schizophrenia: perspective in the era of "atypical" antipsychotic agents. Am J Psychiatry 157:1379-1389, 2000
- Siris SG, Lavin MR: Schizoaffective disorder, schizophreniform disorder and acute psychotic disorder (including brief reactive psychosis), in Comprehensive Textbook of Psychiatry/VI, 6th Edition. Edited by Kaplan HI, Sadock BJ. Philadelphia, PA, Williams & Wilkins, 1995, pp 1019-1031
- Siris SG, Morgan V, Fagerstrom R, et al: Adjunctive imipramine in the treatment of post-psychotic depression: a controlled trial. Arch Gen Psychiatry 44:533-539, 1987
- Siris SG, Adan F, Cohen M, et al: Post-psychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 145:1532-1537, 1988a
- Siris SG, Strahan A, Mandeli J, et al: Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression. Schizophr Res 1:31-35, 1988b
- Siris SG, Bermanzohn PC, Mason SE, et al: Maintenance imipramine therapy for secondary depression in schizophrenia: a controlled trial. Arch Gen Psychiatry 51:109-115, 1994
- Spina E, DeDomenico P, Ruello C, et al: Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients. Int Clin Psychopharmacol 9:281-285, 1994
- Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 35:773-782, 1978
- Stephens JH, Richard P, McHugh PR: Suicide in patients hospitalized for schizophrenia: 1913-1940. J Nerv Ment Dis 187:10-14, 1999
- Strian F, Heger R, Klicpera C: The time structure of depressive mood in schizophrenic patients. Acta Psychiatr Scand 65:66-73, 1982
- Szymanski HV, Simon J, Gutterman N: Recovery from schizophrenic psychosis. Am J Psychiatry 140:335-338, 1983
- Tapp A, Tandon R, Douglass A, et al: Depression in severe chronic schizophrenia. Biol Psychiatry 35:667, 1994
- Taylor MA: Are schizophrenia and affective disorder related? A selective literature review. Am J Psychiatry 149:22-32, 1992
- Tollefson GD, Andersen SW, Tran PV: The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biol Psychiatry 46:365-373, 1999
- Van Putten T: The many faces of akathisia. Compr Psychiatry 16:43-47, 1975
- Van Putten T, May PRA: 'Akinetic depression' in schizophrenia. Arch Gen Psychiatry 35:1101-1107, 1978
- Waehrens J, Gerlach J: Antidepressant drugs in anergic schizophrenia: a doubleblind cross-over study with maprotiline and placebo. Acta Psychiatr Scand 61:438-444, 1980
- Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669, 1987
- Winokur G: Family history studies, VIII: secondary depression is alive and well, and . . . Diseases of the Nervous System 33:94-99, 1972
- Wise RA: Neuroleptics and operant behaviour: the anhedonia hypothesis. Behav Brain Sci 5:39-87, 1982
- Wistedt B, Palmstierna T: Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics. J Clin Psychiatry 44:369-371, 1983
- World Health Organization: International Classification of Diseases (ICD-10): Clinical Descriptions and Diagnostic Guidelines (draft of field trials). Geneva, World Health Organization, 1988
- Zubin J, Spring B: Vulnerability: a new view of schizophrenia. J Abnorm Psychol 86: 103-126, 1977